AU2002322424A8 - Novel methods and formulations for administration of active agents - Google Patents

Novel methods and formulations for administration of active agents

Info

Publication number
AU2002322424A8
AU2002322424A8 AU2002322424A AU2002322424A AU2002322424A8 AU 2002322424 A8 AU2002322424 A8 AU 2002322424A8 AU 2002322424 A AU2002322424 A AU 2002322424A AU 2002322424 A AU2002322424 A AU 2002322424A AU 2002322424 A8 AU2002322424 A8 AU 2002322424A8
Authority
AU
Australia
Prior art keywords
formulations
administration
active agents
novel methods
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002322424A
Other versions
AU2002322424A1 (en
Inventor
Joseph A Manda
Garfield P Royer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royer Biomedical Inc
Original Assignee
Royer Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royer Biomedical Inc filed Critical Royer Biomedical Inc
Publication of AU2002322424A1 publication Critical patent/AU2002322424A1/en
Publication of AU2002322424A8 publication Critical patent/AU2002322424A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002322424A 2001-07-31 2002-02-26 Novel methods and formulations for administration of active agents Abandoned AU2002322424A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30859301P 2001-07-31 2001-07-31
US60/308,593 2001-07-31
PCT/US2002/021646 WO2003011214A2 (en) 2001-07-31 2002-02-26 Novel methods and formulations for administration of active agents

Publications (2)

Publication Number Publication Date
AU2002322424A1 AU2002322424A1 (en) 2003-02-17
AU2002322424A8 true AU2002322424A8 (en) 2009-07-30

Family

ID=23194577

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002322424A Abandoned AU2002322424A1 (en) 2001-07-31 2002-02-26 Novel methods and formulations for administration of active agents

Country Status (2)

Country Link
AU (1) AU2002322424A1 (en)
WO (1) WO2003011214A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7456306B2 (en) * 2003-07-28 2008-11-25 Mallinckrodt Inc Stearate composition and method of production thereof
WO2005039537A1 (en) 2003-10-22 2005-05-06 Lidds Ab Composition comprising biodegradable hydrating ceramics for controlled drug delivery
WO2006023035A2 (en) * 2004-07-28 2006-03-02 Mallinckrodt Inc. Improved stearate composition and method of production thereof
NZ552290A (en) * 2006-12-21 2009-05-31 Bomac Research Ltd Tablet fomulation
US8142592B2 (en) 2008-10-02 2012-03-27 Mylan Inc. Method for making a multilayer adhesive laminate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3781268A (en) * 1972-01-27 1973-12-25 Bristol Myers Co Antibiotic derivatives of kanamycin
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US6497901B1 (en) * 2000-11-02 2002-12-24 Royer Biomedical, Inc. Resorbable matrices for delivery of bioactive compounds

Also Published As

Publication number Publication date
WO2003011214A2 (en) 2003-02-13
WO2003011214A3 (en) 2009-06-11
AU2002322424A1 (en) 2003-02-17

Similar Documents

Publication Publication Date Title
EP1337249A4 (en) Compositions and methods for administration of pharmacologically active compounds
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
EP1165048A4 (en) Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
PT1412384E (en) Stable formulation of modified glp-1
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
HK1048247A1 (en) Stable carotene-xanthophyll beadlet compositions and methods of use
HUP0303732A2 (en) Hsa-free formulations of interferon-beta
EP1416884A4 (en) Delivery of therapeutic capable agents
AU2002243277A1 (en) Methods and compositions for encapsulating active agents
IL157741A0 (en) Pharmaceutical compositions containing an antihyperplastic active agent
AU6118001A (en) Combination therapeutic compositions and methods of use
EP1227821A4 (en) Therapeutic compositions and methods of use thereof
EP1183068A4 (en) Method of electroporation-enhanced delivery of active agents
AU2002335046A1 (en) The use of proton sequestering agents in drug formulations
AU2003282782A8 (en) Pharmaceutically active lipid based formulation of sn38
AU2001294920A1 (en) Chrono delivery formulations and method of use thereof
EP1420797A4 (en) Dermal therapy using phosphate derivatives of electron transfer agents
HUP0400548A3 (en) Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma
AU1261501A (en) Compositions and methods for intranasal delivery of active agents to the brain
EP1154997A4 (en) Pharmaceutically active compounds and methods of use thereof
AU9473501A (en) Stabilization of solid drug formulations
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
HUP0303178A3 (en) Methods and compositions for reducing the taste of pharmaceutically active agents
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase